Skip to content

Terumo Neuro Publishes RAGE Study Results for HydroCoil Embolic System Coils

Terumo Neuro announced the publication of results from the RAGE study, the largest prospective trial of HydroCoil Embolic System coils for treating ruptured intracranial aneurysms in North America. The study enrolled over 750 patients and demonstrated favorable outcomes, reinforcing the efficacy and safety of Hydrogel coils in clinical practice. The study reflects advancements in neurovascular care, providing robust evidence supporting the treatment of this life-threatening condition.

Largest prospective, core lab–adjudicated trial in North America confirms strong occlusion, low rebleeding, and favorable functional independence

Largest prospective, core lab–adjudicated trial in North America confirms strong occlusion, low rebleeding, and favorable functional independence